147 related articles for article (PubMed ID: 18164319)
1. Non-steroidal anti-inflammatory drugs have potent anti-fibrillogenic and fibril-destabilizing effects for alpha-synuclein fibrils in vitro.
Hirohata M; Ono K; Morinaga A; Yamada M
Neuropharmacology; 2008 Mar; 54(3):620-7. PubMed ID: 18164319
[TBL] [Abstract][Full Text] [Related]
2. Non-steroidal anti-inflammatory drugs have anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro.
Hirohata M; Ono K; Naiki H; Yamada M
Neuropharmacology; 2005 Dec; 49(7):1088-99. PubMed ID: 16125740
[TBL] [Abstract][Full Text] [Related]
3. Antioxidant compounds have potent anti-fibrillogenic and fibril-destabilizing effects for alpha-synuclein fibrils in vitro.
Ono K; Yamada M
J Neurochem; 2006 Apr; 97(1):105-15. PubMed ID: 16524383
[TBL] [Abstract][Full Text] [Related]
4. Anti-fibrillogenic and fibril-destabilizing activities of anti-Parkinsonian agents for alpha-synuclein fibrils in vitro.
Ono K; Hirohata M; Yamada M
J Neurosci Res; 2007 May; 85(7):1547-57. PubMed ID: 17387689
[TBL] [Abstract][Full Text] [Related]
5. Anti-fibrillogenic and fibril-destabilizing activity of nicotine in vitro: implications for the prevention and therapeutics of Lewy body diseases.
Ono K; Hirohata M; Yamada M
Exp Neurol; 2007 Jun; 205(2):414-24. PubMed ID: 17425956
[TBL] [Abstract][Full Text] [Related]
6. Vitamin A potently destabilizes preformed alpha-synuclein fibrils in vitro: implications for Lewy body diseases.
Ono K; Yamada M
Neurobiol Dis; 2007 Feb; 25(2):446-54. PubMed ID: 17169566
[TBL] [Abstract][Full Text] [Related]
7. Anti-aggregation and fibril-destabilizing effects of sex hormones on alpha-synuclein fibrils in vitro.
Hirohata M; Ono K; Morinaga A; Ikeda T; Yamada M
Exp Neurol; 2009 Jun; 217(2):434-9. PubMed ID: 19289119
[TBL] [Abstract][Full Text] [Related]
8. Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro.
Ono K; Hasegawa K; Naiki H; Yamada M
J Neurosci Res; 2004 Mar; 75(6):742-50. PubMed ID: 14994335
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid from patients with multiple system atrophy promotes in vitro α-synuclein fibril formation.
Hirohata M; Ono K; Morinaga A; Ikeda T; Yamada M
Neurosci Lett; 2011 Mar; 491(1):48-52. PubMed ID: 21215793
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid of Alzheimer's disease and dementia with Lewy bodies patients enhances alpha-synuclein fibril formation in vitro.
Ono K; Noguchi-Shinohara M; Yoshita M; Naiki H; Yamada M
Exp Neurol; 2007 Feb; 203(2):579-83. PubMed ID: 17011551
[TBL] [Abstract][Full Text] [Related]
11. Effects of non-steroidal anti-inflammatory drugs on Abeta deposition in Abeta(1-42) transgenic C. elegans.
Morita M; Osoda K; Yamazaki M; Shirai F; Matsuoka N; Arakawa H; Nishimura S
Brain Res; 2009 Oct; 1295():186-91. PubMed ID: 19666013
[TBL] [Abstract][Full Text] [Related]
12. Alpha-synuclein assembly as a therapeutic target of Parkinson's disease and related disorders.
Ono K; Hirohata M; Yamada M
Curr Pharm Des; 2008; 14(30):3247-66. PubMed ID: 19075704
[TBL] [Abstract][Full Text] [Related]
13. Effect of melatonin on α-synuclein self-assembly and cytotoxicity.
Ono K; Mochizuki H; Ikeda T; Nihira T; Takasaki J; Teplow DB; Yamada M
Neurobiol Aging; 2012 Sep; 33(9):2172-85. PubMed ID: 22118903
[TBL] [Abstract][Full Text] [Related]
14. Effects of nitration on the structure and aggregation of alpha-synuclein.
Uversky VN; Yamin G; Munishkina LA; Karymov MA; Millett IS; Doniach S; Lyubchenko YL; Fink AL
Brain Res Mol Brain Res; 2005 Mar; 134(1):84-102. PubMed ID: 15790533
[TBL] [Abstract][Full Text] [Related]
15. In vitro effect of different non-steroidal anti-inflammatory drugs on human polymorphonuclear leukocyte activity measured by luminol-dependent chemiluminescence of the whole blood.
Abdullah AS; Jawad AM; Al-Hashimi AH
Saudi Med J; 2001 Apr; 22(4):360-5. PubMed ID: 11331497
[TBL] [Abstract][Full Text] [Related]
16. Fibrillogenic and non-fibrillogenic ensembles of SDS-bound human alpha-synuclein.
Ahmad MF; Ramakrishna T; Raman B; Rao ChM
J Mol Biol; 2006 Dec; 364(5):1061-72. PubMed ID: 17054982
[TBL] [Abstract][Full Text] [Related]
17. In vitro inhibitory effects of non-steroidal anti-inflammatory drugs on 4-methylumbelliferone glucuronidation in recombinant human UDP-glucuronosyltransferase 1A9--potent inhibition by niflumic acid.
Mano Y; Usui T; Kamimura H
Biopharm Drug Dispos; 2006 Jan; 27(1):1-6. PubMed ID: 16278927
[TBL] [Abstract][Full Text] [Related]
18. Inhibition by non-steroidal anti-inflammatory drugs of compound action potentials in frog sciatic nerve fibers.
Suzuki R; Fujita T; Mizuta K; Kumamoto E
Biomed Pharmacother; 2018 Jul; 103():326-335. PubMed ID: 29665554
[TBL] [Abstract][Full Text] [Related]
19. Non-steroidal anti-inflammatory drugs as anti-amyloidogenic compounds.
Hirohata M; Ono K; Yamada M
Curr Pharm Des; 2008; 14(30):3280-94. PubMed ID: 19075706
[TBL] [Abstract][Full Text] [Related]
20. Pyrroloquinoline quinone (PQQ) prevents fibril formation of alpha-synuclein.
Kobayashi M; Kim J; Kobayashi N; Han S; Nakamura C; Ikebukuro K; Sode K
Biochem Biophys Res Commun; 2006 Oct; 349(3):1139-44. PubMed ID: 16962995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
